{
    "clinical_study": {
        "@rank": "33568", 
        "acronym": "HIFU", 
        "arm_group": {
            "arm_group_label": "Echopulse", 
            "arm_group_type": "Other", 
            "description": "Echopulse HIFU"
        }, 
        "brief_summary": {
            "textblock": "This is a monocenter, open-label, uncontrolled study in accordance with \u00a723b MPG to evaluate\n      the efficacy of the HIFU-treatment of fibroadenoma using the TH-One device\n\n      Objectives Primary objective: To evaluate the efficacy of HIFU in the treatment of the\n      breast fibroadenoma using the TH-One device Secondary objective: To evaluate the\n      tolerability of the HIFU using the TH-One device"
        }, 
        "brief_title": "Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Fibroadenoma", 
        "condition_browse": {
            "mesh_term": "Fibroadenoma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female patients 18 years or older with at least one diagnosed breast fibroadenoma.\n\n          -  Diagnosis of fibroadenoma must be based on:\n\n               -  clinical examination,\n\n               -  women \u2264 40 years of age: ultrasound image alone; women > 40 years of age:\n                  ultrasound image and mammogram,\n\n               -  histological confirmation of fibroadenoma of the breast.\n\n          -  Patient's fibroadenoma size as determined by ultrasound imaging: the longest diameter\n             is limited to 25 mm.\n\n          -  Women of childbearing potential must have a negative urine pregnancy test within 72\n             hours prior to HIFU treatment.\n\n          -  Patient must be able to understand the nature and the extent of the study and the\n             proc\u00e9dures required and be willing and able to complete the screening and study\n             procedures.\n\n          -  Patient must give written informed consent (personally signed and dated) before\n             completing any study-related procedure.\n\n        Exclusion Criteria:\n\n          -  Patient who is pregnant or breast-feeding.\n\n          -  Patient with history of ipsilateral breast cancer within 5 years prior to study\n             inclusion or radio therapy to the target breast within 5 years prior to study\n             inclusion.\n\n          -  Patient with implant on the treated breast.\n\n          -  Patient with target fibroadenoma pre-treated by cryoablation or interstitial laser\n             therapy within 12 month before recruiting for HIFU.\n\n          -  Patient's fibroadenoma not clearly visible on the ultrasound images (in B mode) at\n             the inclusion visit.\n\n          -  Patient participating in other studies using drugs or medical devices within 3 months\n             prior to study inclusion or during study participation including the follow-up\n             period."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "27", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02011919", 
            "org_study_id": "HIFU / TU / FA"
        }, 
        "intervention": {
            "arm_group_label": "Echopulse", 
            "description": "HIFU Under ultrasound guidance", 
            "intervention_name": "Echopulse", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 18, 2013", 
        "location": {
            "contact": {
                "last_name": "Markus Hahn, PD Dr."
            }, 
            "facility": {
                "address": {
                    "city": "Tubingen", 
                    "country": "Germany"
                }, 
                "name": "Tubingen University Hospital"
            }, 
            "investigator": {
                "last_name": "Markus Hahn, PD Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "official_title": "Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)", 
        "overall_contact": {
            "email": "Markus.Hahn@med.uni-tuebingen.de", 
            "last_name": "Markus Hahn, PD Med", 
            "phone": "+49 7071 2982211"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "FA volume", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02011919"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Theraclion", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Theraclion", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}